IL165414A0 - Novel formulation for the parenteral application of crobenetine - Google Patents

Novel formulation for the parenteral application of crobenetine

Info

Publication number
IL165414A0
IL165414A0 IL16541404A IL16541404A IL165414A0 IL 165414 A0 IL165414 A0 IL 165414A0 IL 16541404 A IL16541404 A IL 16541404A IL 16541404 A IL16541404 A IL 16541404A IL 165414 A0 IL165414 A0 IL 165414A0
Authority
IL
Israel
Prior art keywords
crobenetine
parenteral application
novel formulation
formulation
novel
Prior art date
Application number
IL16541404A
Original Assignee
Boehringer Ingelheim Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Pharma filed Critical Boehringer Ingelheim Pharma
Priority to IL16541404A priority Critical patent/IL165414A0/en
Publication of IL165414A0 publication Critical patent/IL165414A0/en

Links

IL16541404A 2004-11-28 2004-11-28 Novel formulation for the parenteral application of crobenetine IL165414A0 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
IL16541404A IL165414A0 (en) 2004-11-28 2004-11-28 Novel formulation for the parenteral application of crobenetine

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IL16541404A IL165414A0 (en) 2004-11-28 2004-11-28 Novel formulation for the parenteral application of crobenetine

Publications (1)

Publication Number Publication Date
IL165414A0 true IL165414A0 (en) 2006-01-15

Family

ID=37215627

Family Applications (1)

Application Number Title Priority Date Filing Date
IL16541404A IL165414A0 (en) 2004-11-28 2004-11-28 Novel formulation for the parenteral application of crobenetine

Country Status (1)

Country Link
IL (1) IL165414A0 (en)

Similar Documents

Publication Publication Date Title
GB0409375D0 (en) Phytoactive composition
EP1726304A4 (en) Solifenacin-containing composition
GB0526419D0 (en) Formulation
EP1928469A4 (en) Fulvestrant formulation
GB0517673D0 (en) Formulation
GB0425795D0 (en) Composition
GB0416861D0 (en) Composition
IL182739A0 (en) Acylatednonadepsipeptides used as lysobactin derivatives
GB0423565D0 (en) Formulation
GB0410038D0 (en) Composition
GB0412530D0 (en) Formulation
GB0414803D0 (en) Composition
ZA200704974B (en) Composition
GB0415981D0 (en) Composition
GB0417357D0 (en) Composition
GB0506035D0 (en) Improved formulation
HU0401379D0 (en) Process for the preparation of risperidon
IL165414A0 (en) Novel formulation for the parenteral application of crobenetine
GB0417388D0 (en) Composition
GB2418924B (en) Weathered-effect composition
PL1591434T3 (en) New 1-methoxy-2-phenyl ethenes useful for the preparation of 5-carboxaldehyde-2-3-dihydrobenzoxepines
GB0409598D0 (en) Composition
GB0426142D0 (en) Formulation
GB0407958D0 (en) Formulation
GB0401114D0 (en) Formulation